INSM250117P82500
- 0.00
- 0.000.00%
Insmed Newsroom
Trending Stocks Today | Aptose Biosciences Surges 159.69% Post-Market
Unpleasant Surprises Could Be In Store For Insmed Incorporated's (NASDAQ:INSM) Shares
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Express News | Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Unusual Options Activity: MCHP, INSM and Others Attract Market Bets, MCHP V/OI Ratio Reaches 326.1
How Is The Market Feeling About Insmed?
Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?
Insmed To Present at December 2024 Investor Conferences
Insmed Insiders Sold US$3.8m Of Shares Suggesting Hesitancy
Insmed Is Maintained at Overweight by JP Morgan
Demystifying Insmed: Insights From 7 Analyst Reviews
Insmed Analyst Ratings
J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $83
Optimistic Revenue Forecast for Insmed Following Brensocatib's Launch and Strategic Developments
Express News | Insmed Inc : JP Morgan Raises Target Price to $83 From $74
BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90
Insmed's Strategic Growth and Market Potential Drive Buy Recommendation
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Top Gap Ups and Downs on Tuesday: SMCI, WMT, BBY and More